Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· December 8, 2025

Antimony Market Becoming a Billion Dollar Revenue Opportunity with Significantly Usage & Growth Expected

View original at globenewswire.com
Antimony Market Becoming a Billion Dollar Revenue Opportunity with Significantly Usage & Growth Expected MarketNewsUpdatesNews Commentary NEW YORK, Dec…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Entering the U.S. market remains a high priority for the Company, aligning with focus on building a geographically diversified critical minerals portfolio

    80% confidence
  • Equipment expected for delivery in January 2026 and company is ahead of schedule, moving towards first expected production by 2026/27

    80% confidence
  • Over 60% of global antimony consumption is utilized in flame retardants, primarily for plastics, textiles, and rubber applications

    80% confidence
  • Staking claims adjacent to Teck Resources' Iron Hills deposit furthers the Company's strategy of seeking out compelling rare earth and critical minerals claims

    80% confidence
  • Nova is rapidly progressing to become a fully-integrated domestic producer of military-grade antimony and is focused on securing a robust domestic supply chain for this vital defence material

    80% confidence
  • Global antimony mineral market size was valued at USD 1.21 billion in 2024 and is projected to reach USD 1.80 billion by 2031, growing at a CAGR of 6.1% during the forecast period

    80% confidence
  • Lead-acid batteries retain over 70% market share in automotive starter applications and dominate industrial energy storage solutions

    80% confidence
  • This work will not only help validate the processing characteristics of our Nevada-sourced material but also advance the broader goal of establishing U.S. refining capability for this critical mineral

    80% confidence
  • This agreement represents another important step in developing a fully integrated, American-controlled supply chain for antimony

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com